GCL
TPTX

Glazer Capital LLC’s Turning Point Therapeutics, Inc. Common Stock TPTX Stock Holding History

Glazer Capital LLC’s Portfolio TPTX Stock Details TPTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-600,368
Closed -$45.2M – 801
2022
Q2 		$45.2M Buy
+600,368
New +$45.2M 1.12% 8